HK2 and hepatocellular carcinoma: For example, HK2 is thought to be involved in tumorigenesis and glycolysis in hepatocellular carcinoma (HCC) cells, and increased HK2 expression in HCC patients is associated with lower overall survival (OS), whereas inhibiting HK2 activity reportedly promoted the therapeutic effect of sorafenib in an in vivo model of HCC.